Work

Reactivation of p53 in TP53-Y220C Mutant AML: Mechanism of Action and Mechanism-Based Drug Combinations

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-208403

Authors: Bing Z. Carter, Po Yee Mak, Baozhen Ke, Xiaogang Wu, Steffen Boettcher, Lauren B. Ostermann, Andrea Bedoy, Georgina Gener-Ricos, Jayastu Senapati, Courtney D. DiNardo, Anna Puzio-Kuter, Arnold Levine, Michael Andreeff

Institutions: The University of Texas MD Anderson Cancer Center, University of Zurich, University Hospital Zurich, PMV Pharmaceuticals, Inc. (United States), Institute for Advanced Study

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039505

Cites:

Cited by:

Related to: 10